09-30-2014, 09:14 AM
<b>Study: CBD Administration Associated With Improved Quality Of Life In Patients With Parkinsons Disease</b>
By Paul Armentano, NORML Deputy Director September 25, 2014
The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, is associated with improved quality of life in patients with Parkinsons disease, according clinical trial data published online ahead of print in the <i>Journal of Psychopharmacology</i>.
Investigators at the University of So Paulo in Brazil assessed the efficacy of CBD versus placebo in 21 subjects with Parkinsons. Authors reported that the administration of 300 mg doses of CBD per day was associated with significantly different mean total scores in subjects well-being and quality of life compared to placebo.
Separate assessments of CBD versus placebo reported that the cannabinoid did not appear to mitigate general symptoms of the disease,...
http://blog.norml.org/2014/09/25/study-c...unF3H.dpuf
By Paul Armentano, NORML Deputy Director September 25, 2014
The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, is associated with improved quality of life in patients with Parkinsons disease, according clinical trial data published online ahead of print in the <i>Journal of Psychopharmacology</i>.
Investigators at the University of So Paulo in Brazil assessed the efficacy of CBD versus placebo in 21 subjects with Parkinsons. Authors reported that the administration of 300 mg doses of CBD per day was associated with significantly different mean total scores in subjects well-being and quality of life compared to placebo.
Separate assessments of CBD versus placebo reported that the cannabinoid did not appear to mitigate general symptoms of the disease,...
http://blog.norml.org/2014/09/25/study-c...unF3H.dpuf